David A. Siegel Organogenesis Holdings Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 489,000 shares of ORGO stock, worth $2.52 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
489,000
Previous 547,400
10.67%
Holding current value
$2.52 Million
Previous $1.57 Million
0.06%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding ORGO
# of Institutions
124Shares Held
62MCall Options Held
4.3KPut Options Held
3.9K-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$64.4 Million2.78% of portfolio
-
Morgan Stanley New York, NY11.8MShares$61 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$26.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$18.5 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.08MShares$15.9 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $675M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...